We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1526
Medtronic
MDT
$108B
$801K ﹤0.01%
9,718
-1,220
-11% -$93K
RSKD icon
1527
Riskified
RSKD
$702M
$800K ﹤0.01%
170,999
-110,617
-39% -$453K
VRNA
1528
DELISTED
Verona Pharma
VRNA
$799K ﹤0.01%
40,215
+24,731
+160% +$365K
XPER icon
1529
Xperi
XPER
$367M
$799K ﹤0.01%
+72,511
New +$699K
SOC.WS
1530
CALL
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$797K ﹤0.01%
70,000
-29,183
-29% -$26.7K
EQT icon
1531
EQT Corp
EQT
$32.5B
$797K ﹤0.01%
20,618
-492,269
-96% -$20M
DHT icon
1532
DHT Holdings
DHT
$2.95B
$797K ﹤0.01%
+81,242
New +$836K
VNDA icon
1533
Vanda Pharmaceuticals
VNDA
$314M
$791K ﹤0.01%
+187,497
New +$757K
ECXWW
1534
CALL
ECARX Holdings Warrants
ECXWW
$790K ﹤0.01%
250,000
-37,342
-13% -$1.26K
ALTG icon
1535
Alta Equipment Group
ALTG
$208M
$789K ﹤0.01%
+63,766
New +$689K
LNG icon
1536
Cheniere Energy
LNG
$53.6B
$787K ﹤0.01%
+4,609
New +$792K
YMAB
1537
DELISTED
Y-mAbs Therapeutics
YMAB
$783K ﹤0.01%
114,786
+15,855
+16% +$91.7K
W icon
1538
Wayfair
W
$12.5B
$777K ﹤0.01%
12,600
-692,425
-98% -$36.2M
DCBO
1539
Docebo
DCBO
$512M
$776K ﹤0.01%
+16,034
New +$715K
ARCC icon
1540
Ares Capital
ARCC
$13.6B
$775K ﹤0.01%
+38,700
New +$755K
XNCR icon
1541
Xencor
XNCR
$1.47B
$770K ﹤0.01%
+36,249
New +$690K
TITN icon
1542
Titan Machinery
TITN
$469M
$767K ﹤0.01%
26,572
-17,670
-40% -$458K
GETY icon
1543
Getty Images
GETY
$173M
$761K ﹤0.01%
144,978
+101,384
+233% +$509K
CERT icon
1544
Certara
CERT
$1.21B
$761K ﹤0.01%
43,238
-418,889
-91% -$6.14M
FCOM icon
1545
Fidelity MSCI Communication Services Index ETF
FCOM
$1.77B
$758K ﹤0.01%
+17,024
New +$710K
GLDD
1546
DELISTED
Great Lakes Dredge & Dock
GLDD
$756K ﹤0.01%
98,464
-67,732
-41% -$493K
TPG icon
1547
TPG
TPG
$6.89B
$756K ﹤0.01%
+17,511
New +$591K
SBOW
1548
DELISTED
SilverBow Resources, Inc.
SBOW
$756K ﹤0.01%
25,988
-61,137
-70% -$1.96M
DXPE icon
1549
DXP Enterprises
DXPE
$2.57B
$755K ﹤0.01%
22,414
-2,486
-10% -$81.2K
CRMT icon
1550
America's Car Mart
CRMT
$27.9M
$755K ﹤0.01%
9,958
+6,164
+162% +$466K

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.